HLA-A and melanoma: Subsequently Chen et al [10] used the pMHC arrays to detect multiple T-cell populations in 11 human leukocyte antigen (HLA)-A*0201 positive patients with resected stage IIC/III and IV melanoma who were undergoing a melanoma-associated peptide vaccine trial.